- Global Pharma News & Resources

PromoCell GmbH receives EXCiPACT™ certification as manufacturer of pharmaceutical excipients to Good Manufacturing Practice (GMP) standards

  • New possibilities: tailor-made cell culture media and reagents that fulfil specific regulatory requirements are now available on request
  • A streamlined process for defining regulatory specifications reduces the overall burden for customers, therefore saving cost & time and minimizing overall risk
  • The company’s entire cell culture media and reagents portfolios are covered by the new certification

Heidelberg, Germany, 26 January 2021 – Life Science NewswirePromoCell, one of the leading European manufacturers of human cell culture and cell biology products, has announced to have successfully completed a comprehensive EXCiPACT™ audit that certifies the company as a manufacturer of pharmaceutical excipients to Good Manufacturing Practice (GMP) standards.

The EXCiPACT™ certification scheme for pharmaceutical excipients provides a GMP standard that is accepted worldwide and builds on PromoCell’s existing ISO 9001:2015 quality management system. “To achieve EXCiPACT GMP certification, PromoCell was required to demonstrate that its pharmaceutical excipients are manufactured according to the GMP guidelines, as well as ensuring compliance in our raw material supply chain, production environment, production processes and storage conditions.,” says Dörte Keimer, Head of Quality Assurance at PromoCell.

The EXCiPACT™ certification brings several benefits to PromoCell’s customers. It minimizes risk by ensuring the high quality of the cell culture media and reagents portfolios when used as pharmaceutical excipients. It also enables PromoCell to attend the growing demand of researchers planning to work under a regulatory environment by providing tailor-made cell culture media and reagents based on these regulatory requirements. “This is achieved by a streamlined definition of raw material specifications and documentation required from our customers, thus reducing the regulatory burden, and ultimately saving cost and time. Thanks to this certification, PromoCell will make important contributions in the transition from research to application,” says Dr. Irma Börksok, CEO of PromoCell.

For further information on PromoCell’s commitment to quality and the EXCiPACT™ certification access the following link or get in touch with the scientific support service at the toll-free number 0800-776 66 23.  

About PromoCell

PromoCell GmbH is a biotech company that helps scientists discover more every day. With 30 years of expertise, we are recognized globally for supplying scientists with the tools and training they need for groundbreaking research.

PromoCell offers more than 7,000 human cell culture and cell biology products, including human primary cells, stem cells, blood cells, media and optimized products for cancer and 3D cell culture. Our products are perfect for in-depth cell culture analysis, with kits and reagents for cell biology such as antibodies, ELISAs, cytokines, and growth factors.

All PromoCell products meet the highest ethical and legal standards. By complying with European biomedical conventions, we respect human rights and donor privacy. And we are committed to quality – in our products, training and customer services.

Each year 600 peer-reviewed publications feature PromoCell products. We operate in over 40 countries around the world, helping scientists with all of their research needs. And we offer over 100 ISO-certified training courses led by a team of in-house scientists at PromoCell Academy.

Editor Details

Last Updated: 27-Jan-2021